Stanford University
Showing 781-800 of 844 Results
-
Riley Juenemann
Ph.D. Student in Computational and Mathematical Engineering, admitted Autumn 2021
BioThird-year Computational and Mathematical Engineering (ICME) PhD Candidate @ Stanford University passionate about research at the intersection of mathematics, computing, and biology.
-
Dominik Juling
Ph.D. Student in Environmental Social Sciences, admitted Autumn 2026
BioDominik Juling is a PhD student in Environmental Social Sciences (EBS). His research examines the intersection of climate change, peace, and conflict, focusing on how urban communities experience and respond to climate stress in ways that dominant security frameworks often fail to anticipate. He uses mixed-method approaches, combining multi-sited ethnography, remote sensing and GIS, and discourse analyses.
Before coming to Stanford, he earned master's degrees from Yale University and the London School of Economics and Political Science in environmental sciences and conflict studies.
He publishes across academic, policy, and public-facing formats in English and German, always exploring new fields, challenges, and questions. -
Maximilian Julve
Clinical Assistant Professor, Medicine - Oncology
BioDr. Max Julve is a medical oncologist and Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine, with a clinical and research focus in solid tumor cellular therapy and melanoma.
Dr. Julve completed his medical training at Barts and The Royal London School of Medicine in the United Kingdom, followed by internal medicine training at teaching hospitals across North and Central London. He was subsequently awarded a National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship in Medical Oncology at Imperial College London. During this time, alongside his clinical training, he conducted translational research within the King’s College London Immunoengineering group, focusing on transcriptional optimization of CAR-T cell therapies.
Dr. Julve later completed advanced clinical fellowships in solid tumor cellular therapy and melanoma at The Royal Marsden Hospital, London, and earned an MD(Res) doctorate investigating the role of immunosuppressive granulocytes in patients receiving immunotherapy.
He is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor cellular therapy, with a particular emphasis on translating mechanistic insights from the laboratory into novel therapeutic strategies for patients.
